Donald R. Schwartz

Gene expression in ovarian cancer reflects both morphology and biological behavior, distinguishing clear cell from other poor-prognosis ovarian carcinomas.

Donald R. Schwartz, Sharon L. R. Kardia, Kerby Shedden et al. · PubMed · 2002 · 430 citations

Tumoral Pathology, Endocrine-related Cancer, Malignant Disease +15

Tight junction proteins claudin-3 and claudin-4 are frequently overexpressed in ovarian cancer but not in ovarian cystadenomas.

Letícia Batista Azevedo Rangel, Rachana Agarwal, Theresa D’Souza et al. · PubMed · 2003 · 341 citations

Remodeling of the extracellular matrix through overexpression of collagen VI contributes to cisplatin resistance in ovarian cancer cells

Cheryl A. Sherman‐Baust, Ashani T. Weeraratna, Letícia Batista Azevedo Rangel et al. · Cancer Cell · 2003 · 340 citations · Full text

Collagen Vi, Health Sciences, Medicine +11

Mouse Model of Human Ovarian Endometrioid Adenocarcinoma Based on Somatic Defects in the Wnt/β-Catenin and PI3K/Pten Signaling Pathways

Rong Wu, Neali Hendrix-Lucas, Rork Kuick et al. · Cancer Cell · 2007 · 312 citations · Full text

Somatic Defects, Pi3k/pten Signaling Pathways, Uterine Receptivity +8

FGF‐20 and DKK1 are transcriptional targets of β‐catenin and FGF‐20 is implicated in cancer and development

Mario Chamorro, Donald R. Schwartz, Alin Vonica et al. · The EMBO Journal · 2004 · 297 citations · Full text